Trial site
Universitaetsklinikum Duesseldorf AöR
- 183running trials
- 49closed trials
The trials here
What the 236 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers21 trials
- Metastatic breast cancer13 trials
- Acute lymphoblastic leukaemia12 trials
- Liver and biliary tract cancer12 trials
- Prostate cancer10 trials
- Systemic sclerosis (scleroderma)10 trials
- Acute myeloid leukaemia9 trials
- Multiple sclerosis9 trials
- Multiple myeloma8 trials
- Ovarian cancer8 trials
- Bladder cancer7 trials
- Colorectal cancer7 trials
- and 66 more
- Phase
- Phase 3139 trials
- Phase 257 trials
- Phase 1/217 trials
- Phase 111 trials
- Phase 2/39 trials
- Phase 43 trials
- Status
- Recruiting101 trials
- Active, not recruiting67 trials
- Completed49 trials
- Not yet recruiting15 trials
- Suspended4 trials
- Lead sponsor
- AstraZeneca11 trials
- Hoffmann-La Roche10 trials
- Novartis Pharmaceuticals7 trials
- GlaxoSmithKline6 trials
- Pfizer6 trials
- and 136 more
Running trials
Not yet recruiting
Recruiting
Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease
Not yet recruiting
A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
A Study of PRO-203 in Healthy Volunteers and Participants with Systemic Sclerosis
Recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease
Recruiting
SGLT2 Inhibition for Cardiovascular Endpoint Reduction in Hypertension
Active, not recruiting
Recruiting
Recruiting
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
Recruiting
Recruiting
Recruiting
Recruiting
Effect of TRI-001 in patients with chronic limb threatening ischemia
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy
Active, not recruiting
Recruiting
Recruiting
Showing 50 of 183.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers13 recruiting
- Acute lymphoblastic leukaemia8 recruiting
- Metastatic breast cancer7 recruiting
- Ovarian cancer6 recruiting
- Acute myeloid leukaemia5 recruiting
- Liver and biliary tract cancer5 recruiting
- Parkinson disease5 recruiting
- Colorectal cancer4 recruiting
- Multiple myeloma4 recruiting
- Prostate cancer4 recruiting
- Systemic sclerosis (scleroderma)4 recruiting
- Bladder cancer3 recruiting
- Heart failure3 recruiting
- Multiple sclerosis3 recruiting
- Rheumatoid arthritis3 recruiting
- Sickle cell disease3 recruiting
- Stroke3 recruiting
- Thalassaemia3 recruiting
- Dermatomyositis and polymyositis (myositis)2 recruiting
- Diffuse large B-cell lymphoma2 recruiting
- Endometrial cancer2 recruiting
- Follicular lymphoma2 recruiting
- Hidradenitis suppurativa2 recruiting
- High blood pressure2 recruiting
- Lupus (SLE)2 recruiting
- Macular degeneration2 recruiting
- Mantle cell lymphoma2 recruiting
- Myelodysplastic syndromes2 recruiting
- Pancreatic cancer2 recruiting
- Triple-negative breast cancer2 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Atrial fibrillation1 recruiting
- Brain metastases1 recruiting
- Bronchiectasis1 recruiting
- Chronic kidney disease1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Chronic spontaneous urticaria1 recruiting
- Coronary artery disease1 recruiting
- Cytomegalovirus infection1 recruiting
- Diabetic eye disease1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- HIV1 recruiting
- Huntington's disease1 recruiting
- Kidney cancer1 recruiting
- Multiple system atrophy1 recruiting
- Myasthenia gravis1 recruiting
- Myocarditis1 recruiting
- Obesity1 recruiting
- Peripheral artery disease1 recruiting
- Polycystic kidney disease1 recruiting
- Sarcoidosis1 recruiting
- Sarcoma1 recruiting
- Sjögren's disease1 recruiting
- Turner syndrome1 recruiting
- Type 2 diabetes1 recruiting
- Vitiligo1 recruiting
Closed trials
Recruiting
Completed
Completed
Completed
Completed
Active, not recruiting
Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Completed
Completed
Completed
Active, not recruiting
Active, not recruiting
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
Completed
Completed
Completed
Active, not recruiting
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026